SLC7A5 and non-Hodgkin lymphoma: JPH203 also inhibited proliferation of all three lymphoma cell lines but not that of HEK293 cells (Fig. 8C–F), suggesting that inhibition of LAT1 is a potent therapeutic modality for NHL.